Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1975-12-22
1977-07-26
Sebastian, Leland A.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, A61K 4300
Patent
active
040383784
ABSTRACT:
The presence of hepatitis B antigen in serum or plasma can be detected by this technique. Commercially available imitation or cultured pearls coated with antibody to hepatitis B antigen are first reacted with the sample and subsequently reacted with radioactively labeled antibody to hepatitis B antigen. Hepatitis B antigen present in the sample forms a complex consisting of non-radioactive antibody-antigen-and radioactive antibody. The radioactivity emanating from these complexes on pearls is measured. This is indicative of the extent of binding of radioactive antibody and thereby indicating the presence or absence of hepatitis B antigen in an unknown sample.
REFERENCES:
patent: 3794467 (1974-02-01), Adams et al.
patent: 3896218 (1975-07-01), Charm et al.
Catt et al., Nature, vol. 213, No. 5078, pp. 825-827, (Feb. 25, 1967).
LandOfFree
Radioimmunoassay for hepatitis B antigen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Radioimmunoassay for hepatitis B antigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Radioimmunoassay for hepatitis B antigen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-726741